We sure are at the cutting edge, one would hope that the clinicians involved in the trial would know about pseudo-progression and would encourage / ensure patients do not drop off the trial over fears of initial tumour growth. If they are unaware of this recent discovery, then why?
IMU Price at posting:
8.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)